Abstract:Soft-tissue filler injection, the most common nonsurgical procedure in plastic surgery, may be followed by severe complications, such as vision loss and death.1–3 There are limited effective treatment strategies to reverse these events; therefore, prevention is vital.2,3 In this study, fresh frozen cadavers were used for mimetic injections and anatomic study using our injection technique. Between 2018 and 2020, 31 frozen cadavers with Han ethnicity were used in the study. The specimens were perfused with red latex within arteries and blue latex within veins. Cadaver mimetic filler injections with colored hyaluronic acid (HA) were performed with sharp needle and cannula using the following methods. The sharp needle was set perpendicular to the skin surface and penetrated deeply until touching the bone, at which time injection was performed. The cannula was inserted from a prepared hole, located 15 to 20 degrees to the skin surface, and moved forward and backward gently until passing through the tissues, followed by retrograde injection. The HA injected with the sharp needle was located mainly within or under the periosteum and part of the HA would flow reversely into the periosteum or the deep fat compartments (Fig. 1). In terms of cannula injection, in the forehead, temple, periorbital, nose, and nasal labial fold (primarily) regions, the injected HA was located under the superficial muscular aponeurotic system, some of which was in the deep fat compartments, whereas in cheek, lips, mandibular, and nasal labial fold (occasionally), the injected HA was mainly located in the subcutaneous fat layer (Fig. 2).Fig. 1.: Hyaluronic acid (colored black) was injected with a sharp needle in the upper part of the nasolabial fold. The HA was located at the periosteum and some of it (arrows) flowed reversely into the deep medial cheek fat beneath the levator labii superioris (LLS). The facial artery (FA) and its branches including the superior labial artery (SLA) and lateral nasal artery (LNA) are superficial to the injected HA.Fig. 2.: Hyaluronic acid (colored blue) was injected with a cannula in the forehead. Injected HA (arrows) was found under the frontalis, which was the loose connection tissue layer beneath the superficial muscular aponeurotic system. In this specimen, the frontal branches of superficial temporal artery (FBSTA) lie in the frontalis.For the sharp needle, static injection in the periosteum layer after effective withdrawal is recommended. For maximum safety, we chose static injection in the periosteum layer, which has fewer blood vessels, rather than motional injection in other tissue layers.4 For the cannula, retrograde injection after gentle insertion into loose tissues is recommended. The distribution of injected HA by cannula cannot be controlled as expected by the operator, because the cannula cannot be inserted into tissues as freely as the sharp needle. It cannot pass through dense tissues with a gentle push; it can only pass through loose tissues, usually located beneath the superficial muscular aponeurotic system (sub–orbicularis oculi fat and retro-orbicularis oculi fat in the periorbital area, deep medial cheek fat in the upper part of the nasolabial fold, tissue spaces in the temporal and masseter muscle areas, or loose connective tissue in the forehead) (Fig. 2). There are several exceptions. In the lips, loose tissue is located between the orbicularis oris and skin or mucosa. In the mandible and cheek area, the cannula usually enters the subcutaneous fat layer and is difficult to guide into the deep surface of the superficial muscular aponeurotic system, because the superficial fat lay here is relatively thick, providing sufficient loose space for cannula staying.5 In the nasal labial fold, the injected hyaluronic acid sometimes was also found in the superficial fat layer. [See Figure, Supplemental Digital Content 1, which shows the blue hyaluronic acid injected with cannula in the nasolabial fold. Hyaluronic acid was mainly found in the deep medial cheek fat (DMCF), deep surface of the levator labii superioris (LLS), and levator labii superioris alaeque nasi (LLSAN). The facial artery (FA) was beside the hyaluronic acid (left). (Right) The injected hyaluronic acid (arrows) was also occasionally located in subcutaneous fat on the superficial lay of LLS and LLSAN, https://links.lww.com/PRS/F553.] ACKNOWLEDGMENT This study was funded by Zhejiang Province Public Welfare Technology Research Program (LGF21H150004). DISCLOSURE The authors have no financial interest to declare in relation to the content of this article.

Depth of the subcutaneous tissue in the nose: Application to filler injection

Vasculature of the Nasal Cartilage Region Related to Filler Injection

Hyaluronic acid filler injection for deep nasolabial folds: a novel intraoral approach

Fillers Around the Nose

Best Practices for the Use of High-Frequency Ultrasound to Guide Aesthetic Filler Injections—Part 2: Middle Third of the Face, Nose, and Tear Troughs

Nose Tip Elongation and Elevation: A Novel Filler Injection Technique

Microinjection Technique: A Novel and Comprehensive Approach for Nose Reshaping with Hyaluronic Acid Fillers

Cannula Versus Sharp Needle for Placement of Soft Tissue Fillers: An Observational Cadaver Study

Lower Nose Arterial Plexus and Implications for Safe Filler Injections

Singular entry point technique for forehead and temple filler augmentation: Anatomical and clinical perspectives

Treatment of Delayed Hypersensitivity After Injection of Nasal Fillers

Best Practices for the Use of High-Frequency Ultrasound to Guide Aesthetic Filler Injections-Part 1: Upper Third of the Face

Anatomic Study of Fillers: Mimetic Injections for Maximum Safety

Intracorporeal evaluation of hyaluronic acid fillers with varied rheological properties and correlations with aesthetic outcomes

An Innovative Approach for Nasal Reshaping using Hyaluronic Acid Intradermal Injections

Comparative split‐face study of durational changes in hyaluronic acid fillers for mid‐face volume augmentation

Hyaluronic Acid After Subcutaneous Injection—An Objective Assessment

Anatomy of the temporal region to guide filler injections

Studying Dynamics of Mid-face Lifting During Hyaluronic Acid Filler Injection Using Ultrasound Imaging

Efficacy and Safety of Resilient Hyaluronic Acid Fillers Injected with a Cannula: A Randomized, Evaluator-Blinded, Split-Face Controlled Study

Delayed Diagnosis of Septal Ulcer after Hyaluronic Acid Nasal Filler Injection